Dual-target PSMA/PSCA CAR-NK Cells in Advanced Prostate Cancer

Clinical trial NCT07641049 · RECRUITING

Trial details

NCT number: NCT07641049
Sponsor: Beijing Biotech
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Castration-resistant Prostate Cancer Advanced Prostate Adenocarcinoma PSCA-positive Prostate Cancer PSMA-Positive Progressive Metastatic Castration-Resistant Prostate Cancer

Start date: 2026-03-02
Primary completion: 2027-03-14
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.